The global dialyzer market is anticipated to witness a significant growth on account of the rising numbers of patients suffering from end-stage renal disease, diabetes, and hypertension. Factors supporting market growth are the rising geriatric census, technological advancements in products, private investments supporting new products, low patient preference for kidney transplantation, and increased expenditure for end-stage renal disease treatments by governments. The growing numbers of dialysis centers, increased support for home dialysis, and huge growth opportunities in developing markets offer considerable growth opportunities for the leading market players.
However, the factors such as low customer awareness about kidney diseases and their respective treatments are said to hamper market growth. In addition, high procedural prices and the huge competition among market players are major challenges faced by the market.
For Market Research Report on “Dialyzer Market” Visit -http://www.hexaresearch.com/research-report/global-and-china-dialyzer-market/
The global dialyzer market is segmented by end-users, services, and geographies. End-users include in-center and home dialysis. The in-center dialysis sector refers to hospitals and independent dialysis centers; while the home dialysis sector caters to home hemodialysis and peritoneal dialysis.
Services of the market include hemodialysis and peritoneal dialysis. The hemodialysis sector held the largest share of the global dialysis market. This sector includes water treatment systems and its sub-segments. Water treatment systems are further sub-divided into portable water disinfection system and central water disinfection system. Methods of hemodialysis are nocturnal, conventional, and short daily hemodialysis. The peritoneal dialysis sector includes concentrates/dialysates, peritoneal dialysis services, machines, transfer sets, and catheters.
Geographically, North America accounted for the biggest share of the dialyzer market. This can be attributed to factors such as the rapid adoption rates of the latest technology, structured reimbursement system, a lot of well-equipped dialysis centers/hospitals with highly skilled nephrologists in the region. The Asia-Pacific (APAC) region is anticipated to witness significant growth. This can be attributed to the growing cases of end-stage renal diseases, the growing independent dialysis centers, the rising awareness of the latest dialysis treatment modalities, improving reimbursement & insurance scenario, and expansion of global market participants etc.
Although the dialyzer demands are rising annually, novice entrants must be equipped with quality & cost advantages in order to compete with major players. Some of the major companies operating in the global dialyzer market include Angelini Pharma Inc., Atlantic Biomedical Pvt. Ltd., and Chengdu Weilisheng Biotech Co., Ltd.